Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanara MedTech (SMTI)
NASDAQ:SMTI
Holding SMTI?
Track your performance easily
SMTI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$26.00 - $43.25
Previous Close$35
Volume25.53K
Average Volume (3M)25.83K
Market Cap
$306.14M
Enterprise Value$317.84M
Total Cash (Recent Filing)$6.15M
Total Debt (Recent Filing)$18.16M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Mar 26, 2025EPS Estimate
-$0.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.78
Shares Outstanding8,746,976
10 Day Avg. Volume28,434
30 Day Avg. Volume25,827
Standard Deviation0.19
R-Squared0.18
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)7.25
Price to Sales (P/S)4.23
Price to Cash Flow (P/CF)-54.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.39
Enterprise Value/Gross Profit5.56
Enterprise Value/Ebitda-364.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Sanara MedTech News
PremiumCompany Announcements
Sanara MedTech Reports Strong Revenue Growth Amid Challenges
PremiumPre-Earnings
Is SMTI a Buy, Before Earnings?
PremiumCompany Announcements
Sanara MedTech Board Evolution with Strategic New Appointment
PremiumCompany Announcements
Sanara MedTech Appoints Ronald T. Nixon as CEO with Incentive-Based Pay
PremiumCompany Announcements
Sanara MedTech Expands Portfolio with ChemoMouthpiece Investment
Ownership Overview
52.68% Insiders
2.92% Mutual Funds
0.25% Other Institutional Investors
40.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SMTI FAQ
What was Sanara MedTech’s price range in the past 12 months?
Sanara MedTech lowest stock price was $26.00 and its highest was $43.25 in the past 12 months.
What is Sanara MedTech’s market cap?
Currently, no data Available
When is Sanara MedTech’s upcoming earnings report date?
Sanara MedTech’s upcoming earnings report date is Mar 26, 2025 which is in 124 days.
How were Sanara MedTech’s earnings last quarter?
Sanara MedTech released its earnings results on Nov 12, 2024. The company reported -$0.34 earnings per share for the quarter, beating the consensus estimate of -$0.62 by $0.28.
Is Sanara MedTech overvalued?
According to Wall Street analysts Sanara MedTech’s price is currently Overvalued.
Does Sanara MedTech pay dividends?
Sanara MedTech does not currently pay dividends.
What is Sanara MedTech’s EPS estimate?
Sanara MedTech’s EPS estimate is -$0.7.
How many shares outstanding does Sanara MedTech have?
Sanara MedTech has 8,746,976 shares outstanding.
What happened to Sanara MedTech’s price movement after its last earnings report?
Sanara MedTech reported an EPS of -$0.34 in its last earnings report, beating expectations of -$0.62. Following the earnings report the stock price went down -1.143%.
Which hedge fund is a major shareholder of Sanara MedTech?
Currently, no hedge funds are holding shares in SMTI
---
Sanara MedTech Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.90%
12-Months-Change
Fundamentals
Return on Equity
-15.85%
Trailing 12-Months
Asset Growth
25.92%
Trailing 12-Months
Company Description
Sanara MedTech
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
---
SMTI Company Deck
---
SMTI Earnings Call
Q2 2024
0:00 / 0:00
---
SMTI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SMTI
1 Year
1 Year Success Rate
4/6 ratings generated profit
1 Year Average Return
+19.35%
reiterated a buy rating 6 months ago
Copying Ross Osborn's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +19.35% per trade.
---